Investors looking to buy in the current stormy stock market should consider prominent U.S. firms that make money, CNBC’s Jim Cramer said Tuesday. “There’s a lot of stocks that I like. I like the classic, great American companies. I think that they’re terrific,” Cramer said, citing names including Raytheon and Johnson & Johnson, whose stock
0 Comments
The major correction DraftKings (NASDAQ:DKNG) has been on since early September has seen DKNG stock lose almost 70% of its value.  Source: Postmodern Studio / Shutterstock.com Thanks to a terrible first month of 2022 — 374 S&P 500 stocks are down year-to-date through Jan. 21 — DraftKings now trades under $20 for the first time
0 Comments
Exchange-traded funds, or ETFs, provide an alternative means of access for investors seeking potential profits within the aluminum market. Physical aluminum is not available as an investment asset in the same way as metals such as gold, silver, and platinum. Aluminum futures are traded; however, many investors are unfamiliar with trading in the futures markets
0 Comments
Buyers should cool off on cryptocurrency concerns and make some long-term investments instead, SkyBridge Capital’s Anthony Scaramucci told CNBC on Tuesday. Some people think bitcoin is “rat poison,” as billionaire investor Warren Buffett once described it; others think it’s the worst thing to ever happen to civilization, Scaramucci said in a “Squawk Box” interview. “Everyone
0 Comments
I have been a big Nvidia (NASDAQ:NVDA) bull for a long time now. All you have to do is look at a chart of NVDA stock over the past five years to see why. The company continues to dominate competitors and there is seemingly nothing to slow it down.  Source: rafapress / Shutterstock.com When NVDA
0 Comments
Shares of up-and-coming electric vehicle EV startup Canoo (NASDAQ:GOEV) have shed more than 40% of their value in the past six months. GOEV stock has fallen more than 70% from its 52-week high price of $18.88. Overall, its first year of trading was forgettable. Source: shutterstock.com/rafapress 2022 could be a landmark year for the company,
0 Comments
Allakos (NASDAQ:ALLK) is a clinical-stage biopharmaceutical company that recently saw a pretty dramatic price collapse at the end of December. I believe that ALLK stock, and its subsequent collapse, is a learning opportunity for the investing community. Source: Pavel Kapysh/ Shutterstock.com In mid-December 2021, shares of Allakos were trading near $83 per share and they tanked
0 Comments
Among the stocks that underperformed the worst in 2021 were Chinese growth stocks. Indeed, a range of headwinds materialized that saw some of 2020’s best-performing stocks head right back down to earth. That’s perhaps putting the selloff mildly. Starting at the end of 2020, Chinese regulators saw fit to put their foot down, hard, on
0 Comments
Portfolio variance is a measure of the dispersion of returns of a portfolio. It is the aggregate of the actual returns of a given portfolio over a set period of time. Portfolio variance is calculated using the standard deviation of each security in the portfolio and the correlation between securities in the portfolio. Modern portfolio
0 Comments